Popek-Marciniec, S.; Styk, W.; Wojcierowska-Litwin, M.; Chocholska, S.; Szudy-Szczyrek, A.; Samardakiewicz, M.; Swiderska-Kolacz, G.; Czerwik-Marcinkowska, J.; Zmorzynski, S.
Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment. Cancers 2023, 15, 4747.
https://doi.org/10.3390/cancers15194747
AMA Style
Popek-Marciniec S, Styk W, Wojcierowska-Litwin M, Chocholska S, Szudy-Szczyrek A, Samardakiewicz M, Swiderska-Kolacz G, Czerwik-Marcinkowska J, Zmorzynski S.
Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment. Cancers. 2023; 15(19):4747.
https://doi.org/10.3390/cancers15194747
Chicago/Turabian Style
Popek-Marciniec, Sylwia, Wojciech Styk, Magdalena Wojcierowska-Litwin, Sylwia Chocholska, Aneta Szudy-Szczyrek, Marzena Samardakiewicz, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, and Szymon Zmorzynski.
2023. "Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment" Cancers 15, no. 19: 4747.
https://doi.org/10.3390/cancers15194747
APA Style
Popek-Marciniec, S., Styk, W., Wojcierowska-Litwin, M., Chocholska, S., Szudy-Szczyrek, A., Samardakiewicz, M., Swiderska-Kolacz, G., Czerwik-Marcinkowska, J., & Zmorzynski, S.
(2023). Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment. Cancers, 15(19), 4747.
https://doi.org/10.3390/cancers15194747
